Brief: Arrivent Announces Pricing Of $75 Million Public Offering Of Common Stock And Pre-Funded Warrants
02/07/2025 04:15
July 1 (Reuters) - Arrivent Biopharma Inc AVBP.O: ARRIVENT ANNOUNCES PRICING OF $75 MILLION PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS ARRIVENT BIOPHARMA INC - PRICES PUBLIC OFFERING OF 2,482,692 SHARES AT $19.50 PER SHARE Source text: ID:nGNX82NqGh Further company coverage: AVBP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ArriVent BioPharma
See all newsBrief: Arrivent Announces First Patient Dosed With Novel Tetravalent Muc16/Napi2b Dual Target Adc, Arr-002
US RESEARCH ROUNDUP-Allstate, Caribou Biosciences, Zscaler
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
ArriVent falls after lung cancer drug misses late-stage trial goal